- Home
- CHPT vs SCPH Comparison
CHPT vs SCPH Comparison
Compare CHPT & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHPT
- SCPH
- Stock Information
- Founded
- CHPT 2007
- SCPH 2013
- Country
- CHPT United States
- SCPH United States
- Employees
- CHPT N/A
- SCPH N/A
- Industry
- CHPT Industrial Specialties
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- CHPT Consumer Discretionary
- SCPH Health Care
- Exchange
- CHPT Nasdaq
- SCPH Nasdaq
- Market Cap
- CHPT 340.1M
- SCPH 299.0M
- IPO Year
- CHPT N/A
- SCPH 2017
- Fundamental
- Price
- CHPT $11.55
- SCPH $5.67
- Analyst Decision
- CHPT Hold
- SCPH Buy
- Analyst Count
- CHPT 11
- SCPH 3
- Target Price
- CHPT $18.40
- SCPH $12.00
- AVG Volume (30 Days)
- CHPT 490.7K
- SCPH 2.0M
- Earning Date
- CHPT 09-03-2025
- SCPH 11-12-2025
- Dividend Yield
- CHPT N/A
- SCPH N/A
- EPS Growth
- CHPT N/A
- SCPH N/A
- EPS
- CHPT N/A
- SCPH N/A
- Revenue
- CHPT $397,731,000.00
- SCPH $49,969,000.00
- Revenue This Year
- CHPT N/A
- SCPH $104.30
- Revenue Next Year
- CHPT $11.08
- SCPH $76.06
- P/E Ratio
- CHPT N/A
- SCPH N/A
- Revenue Growth
- CHPT N/A
- SCPH 107.79
- 52 Week Low
- CHPT $8.55
- SCPH $1.94
- 52 Week High
- CHPT $30.00
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- CHPT 60.54
- SCPH 64.40
- Support Level
- CHPT $10.62
- SCPH $5.64
- Resistance Level
- CHPT $12.40
- SCPH $5.65
- Average True Range (ATR)
- CHPT 0.62
- SCPH 0.03
- MACD
- CHPT -0.01
- SCPH -0.02
- Stochastic Oscillator
- CHPT 62.46
- SCPH 66.67
About CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.